Lantern Pharma Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.65

+0.02 (+0.76%)

As of Aug 14, 10:17 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +880.4% upside

Low Target $20.93

Average Target $25.98

High Target $39.39

Current Price $2.65

Current
$2.65

Target
$25.98

$20.93 $25.98 avg $39.39

Scenario Analysis

Bear Case

$20.93

689.8%

Low target

Base Case

$25.98

+880.4%

Avg target

Bull Case

$39.39

+1,386.4%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$5.74

-53.9% from high

52-Week Low

$1.11

+138.7% from low

Target vs 52W High

$25.98

+352.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%